Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01155492 · ClinicalTrials.gov registry record
Increased Gut Permeability to Lipopolysaccharides (LPS) in Parkinson's Disease
A clinical trial, sponsored by Rush University Medical Center.
- Completed
- Registry status
- 43
- Enrollment target
NCT01155492 is a clinical trial that has completed, run by Rush University Medical Center. The registered enrollment target is 43 participants.
The verdict
NCT01155492 has completed, sponsored by Rush University Medical Center.
- COMPLETED
- Registry status
- 43 participants
- Enrollment target
Study Summary
The gut may be a portal of entry for agents that cause or contribute to the causes of Parkinson's disease (PD). The investigators are studying changes in the normal population of gut flora and in intestinal permeability and their associations with early PD.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2007-09 |
| Est. Completion | 2013-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01155492
The ClinicalTrials.gov registry entry for NCT01155492 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 43 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rush University Medical Center, which has 320 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01155492 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01155492 about?
NCT01155492 is a clinical study titled "Increased Gut Permeability to Lipopolysaccharides (LPS) in Parkinson's Disease". The gut may be a portal of entry for agents that cause or contribute to the causes of Parkinson's disease (PD). The investigators are studying changes in the normal population of gut flora and in intestinal permeability and their associations with early PD.
What is the current status of trial NCT01155492?
This trial is currently completed. The enrollment target is 43 participants. The study started on 2007-09. Estimated completion is 2013-02.
Who is sponsoring clinical trial NCT01155492?
This trial is sponsored by Rush University Medical Center, which has 320 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.